Latest News | Natco Board Approves Proposal to Acquire US-based Firm

New Delhi, Dec 14 (PTI) Natco Pharma on Tuesday said its board has approved a proposal to acquire US-based Dash Pharmaceuticals LLC for a cash consideration of USD 18 million.

The company's board has approved to acquire Dash Pharmaceuticals through one of its subsidiary units, the drugmaker said in a regulatory filing.

Also Read | Oppo Air Glass With Cicada Wing Design & Spark Micro Projector Introduced, Check Details Here.

Natco, through its affiliates, is proposing to enter into an agreement to acquire Dash Pharmaceuticals subject to the satisfactory completion of due diligence, execution of definitive agreements, and compliance with statutory requirements, it added.

Dash is a front-end pharmaceutical sales, marketing and distribution entity based in New Jersey, USA, which is expected to have around net sales of USD 15 million for the year ending December 2021.

Also Read | Elon Musk-Owned Tesla Now Has 7 EV Variants Approved for Homologations in India.

This acquisition will provide the company with a front-end to engage with its customers directly in the US, which is the largest pharmaceutical market in the world, Natco Pharma noted.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)